Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 96 | 2024 | 11124 | 4.460 |
Why?
|
Prostate-Specific Antigen | 13 | 2023 | 2494 | 1.290 |
Why?
|
Polymorphism, Single Nucleotide | 49 | 2023 | 15519 | 1.280 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12261 | 1.140 |
Why?
|
Kallikreins | 2 | 2020 | 258 | 1.000 |
Why?
|
Prostate | 11 | 2023 | 1774 | 0.980 |
Why?
|
Selenium | 4 | 2016 | 405 | 0.870 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2021 | 55 | 0.800 |
Why?
|
Genetic Predisposition to Disease | 30 | 2023 | 17446 | 0.790 |
Why?
|
Serine Endopeptidases | 5 | 2023 | 1072 | 0.730 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2023 | 2015 | 0.660 |
Why?
|
Chromosomes, Human, Pair 8 | 5 | 2018 | 460 | 0.600 |
Why?
|
Fecal Incontinence | 1 | 2019 | 239 | 0.580 |
Why?
|
Metformin | 2 | 2014 | 835 | 0.560 |
Why?
|
Metabolomics | 3 | 2021 | 1484 | 0.520 |
Why?
|
Urinary Incontinence | 1 | 2019 | 496 | 0.510 |
Why?
|
PTEN Phosphohydrolase | 5 | 2021 | 1142 | 0.500 |
Why?
|
Genotype | 25 | 2024 | 12951 | 0.480 |
Why?
|
Selenoprotein P | 1 | 2012 | 32 | 0.440 |
Why?
|
Follow-Up Studies | 22 | 2024 | 39050 | 0.440 |
Why?
|
Male | 101 | 2024 | 350118 | 0.420 |
Why?
|
Genetic Variation | 12 | 2016 | 6544 | 0.410 |
Why?
|
Gene Expression Profiling | 8 | 2023 | 9438 | 0.390 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2541 | 0.390 |
Why?
|
Case-Control Studies | 30 | 2023 | 21746 | 0.370 |
Why?
|
Genetic Markers | 5 | 2022 | 2634 | 0.370 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2023 | 1581 | 0.360 |
Why?
|
Selenoproteins | 2 | 2016 | 216 | 0.350 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2916 | 0.330 |
Why?
|
Aged | 57 | 2024 | 163280 | 0.320 |
Why?
|
Repressor Proteins | 1 | 2019 | 3023 | 0.320 |
Why?
|
Prostatectomy | 8 | 2020 | 1890 | 0.310 |
Why?
|
Neoplasm Staging | 10 | 2021 | 11031 | 0.310 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 437 | 0.300 |
Why?
|
Humans | 109 | 2024 | 744343 | 0.290 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2023 | 424 | 0.290 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4462 | 0.280 |
Why?
|
Tissue Array Analysis | 4 | 2021 | 553 | 0.280 |
Why?
|
Germ-Line Mutation | 4 | 2023 | 1788 | 0.260 |
Why?
|
Risk Factors | 32 | 2023 | 72290 | 0.260 |
Why?
|
Twins, Dizygotic | 2 | 2016 | 236 | 0.240 |
Why?
|
Prospective Studies | 24 | 2024 | 53288 | 0.240 |
Why?
|
Middle Aged | 48 | 2021 | 213383 | 0.230 |
Why?
|
Genetic Loci | 4 | 2021 | 2575 | 0.230 |
Why?
|
Organic Anion Transporters | 1 | 2024 | 100 | 0.230 |
Why?
|
Twins, Monozygotic | 2 | 2016 | 458 | 0.230 |
Why?
|
RNA, Messenger | 4 | 2017 | 13033 | 0.220 |
Why?
|
Prognosis | 12 | 2022 | 29063 | 0.220 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2015 | 315 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2023 | 8428 | 0.220 |
Why?
|
Proportional Hazards Models | 9 | 2020 | 12354 | 0.210 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2021 | 29 | 0.200 |
Why?
|
Superoxide Dismutase | 2 | 2015 | 597 | 0.200 |
Why?
|
Cohort Studies | 18 | 2024 | 40561 | 0.200 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 2872 | 0.200 |
Why?
|
Aged, 80 and over | 19 | 2022 | 57776 | 0.190 |
Why?
|
Urinary Bladder, Overactive | 1 | 2022 | 106 | 0.190 |
Why?
|
Risk | 9 | 2021 | 9687 | 0.190 |
Why?
|
Multifactorial Inheritance | 3 | 2023 | 1194 | 0.180 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2022 | 548 | 0.170 |
Why?
|
Disease Progression | 10 | 2017 | 13284 | 0.170 |
Why?
|
Confidence Intervals | 3 | 2021 | 2971 | 0.160 |
Why?
|
Serine Proteases | 1 | 2018 | 52 | 0.160 |
Why?
|
Linkage Disequilibrium | 8 | 2012 | 1997 | 0.160 |
Why?
|
Quality of Life | 1 | 2019 | 12804 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3255 | 0.150 |
Why?
|
Odds Ratio | 7 | 2021 | 9849 | 0.150 |
Why?
|
Drug Eruptions | 1 | 2020 | 297 | 0.150 |
Why?
|
Body Height | 2 | 2021 | 1577 | 0.150 |
Why?
|
Environment | 1 | 2023 | 1124 | 0.150 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 206 | 0.150 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2703 | 0.150 |
Why?
|
Transurethral Resection of Prostate | 1 | 2017 | 83 | 0.140 |
Why?
|
Squalene Monooxygenase | 1 | 2016 | 11 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 849 | 0.140 |
Why?
|
Inheritance Patterns | 1 | 2019 | 340 | 0.140 |
Why?
|
Glutathione Peroxidase | 2 | 2016 | 255 | 0.140 |
Why?
|
Quantitative Trait Loci | 3 | 2019 | 2019 | 0.140 |
Why?
|
Age Factors | 3 | 2022 | 18370 | 0.140 |
Why?
|
Neurosecretory Systems | 1 | 2017 | 231 | 0.140 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 349 | 0.130 |
Why?
|
Chromosome Mapping | 5 | 2018 | 4740 | 0.130 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 841 | 0.130 |
Why?
|
Haplotypes | 8 | 2018 | 2779 | 0.130 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 3616 | 0.130 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5751 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 9959 | 0.130 |
Why?
|
Risk Assessment | 12 | 2022 | 23338 | 0.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2023 | 123 | 0.120 |
Why?
|
Molecular Epidemiology | 2 | 2014 | 468 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3870 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1676 | 0.120 |
Why?
|
Electroretinography | 1 | 2016 | 509 | 0.120 |
Why?
|
Breast Neoplasms | 9 | 2022 | 20822 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2018 | 1147 | 0.120 |
Why?
|
Genes, BRCA1 | 2 | 2010 | 781 | 0.120 |
Why?
|
Body Mass Index | 5 | 2021 | 12720 | 0.120 |
Why?
|
Catalase | 1 | 2014 | 222 | 0.120 |
Why?
|
Survival Analysis | 4 | 2015 | 10252 | 0.120 |
Why?
|
Genes, myc | 2 | 2017 | 399 | 0.110 |
Why?
|
Epigenomics | 1 | 2018 | 903 | 0.110 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1420 | 0.110 |
Why?
|
Models, Statistical | 2 | 2021 | 5102 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 770 | 0.110 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.110 |
Why?
|
Receptors, Calcitriol | 2 | 2012 | 350 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1355 | 0.100 |
Why?
|
Metabolome | 1 | 2018 | 895 | 0.100 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 3086 | 0.100 |
Why?
|
Vitamin E | 1 | 2016 | 869 | 0.100 |
Why?
|
Mendelian Randomization Analysis | 3 | 2023 | 967 | 0.100 |
Why?
|
Vitamin D | 4 | 2012 | 3223 | 0.100 |
Why?
|
Receptors, Adiponectin | 1 | 2011 | 81 | 0.100 |
Why?
|
Prostatic Secretory Proteins | 1 | 2010 | 25 | 0.100 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6895 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 390 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 5867 | 0.100 |
Why?
|
Cholesterol | 2 | 2018 | 2917 | 0.090 |
Why?
|
Adult | 19 | 2021 | 214055 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3586 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2020 | 2938 | 0.090 |
Why?
|
Neoplasms | 2 | 2016 | 21683 | 0.090 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 59 | 0.090 |
Why?
|
Energy Intake | 1 | 2018 | 2148 | 0.090 |
Why?
|
Genetics, Population | 2 | 2006 | 934 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 287 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.090 |
Why?
|
Gene Fusion | 1 | 2012 | 371 | 0.080 |
Why?
|
Logistic Models | 3 | 2021 | 13408 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2503 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3920 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2018 | 6364 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3527 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 229 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 503 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2013 | 12026 | 0.080 |
Why?
|
Paraffin Embedding | 2 | 2020 | 299 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 565 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2849 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2017 | 3690 | 0.070 |
Why?
|
Sequence Tagged Sites | 1 | 2006 | 94 | 0.070 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 528 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2899 | 0.070 |
Why?
|
Signal Transduction | 3 | 2020 | 23403 | 0.070 |
Why?
|
Mutation, Missense | 4 | 2010 | 2564 | 0.070 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 314 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2014 | 11366 | 0.070 |
Why?
|
Antioxidants | 1 | 2014 | 1663 | 0.070 |
Why?
|
Gene Dosage | 1 | 2010 | 1252 | 0.070 |
Why?
|
DNA | 1 | 2019 | 7301 | 0.070 |
Why?
|
Adiponectin | 1 | 2011 | 1100 | 0.070 |
Why?
|
Obesity | 3 | 2018 | 12745 | 0.070 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7722 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3778 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2734 | 0.060 |
Why?
|
Survival Rate | 3 | 2020 | 12788 | 0.060 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1377 | 0.060 |
Why?
|
Sweden | 2 | 2017 | 1345 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2010 | 975 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 644 | 0.060 |
Why?
|
BRCA1 Protein | 1 | 2010 | 1149 | 0.060 |
Why?
|
Europe | 2 | 2024 | 3339 | 0.060 |
Why?
|
Incidence | 5 | 2016 | 20947 | 0.050 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2022 | 33 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11524 | 0.050 |
Why?
|
Receptors, Purinergic | 1 | 2022 | 66 | 0.050 |
Why?
|
Marital Status | 1 | 2024 | 437 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2924 | 0.050 |
Why?
|
Time Factors | 3 | 2019 | 40075 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5756 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4838 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 318 | 0.050 |
Why?
|
Biopsy | 2 | 2024 | 6756 | 0.050 |
Why?
|
Receptors, Cholinergic | 1 | 2022 | 238 | 0.050 |
Why?
|
Cholinergic Antagonists | 1 | 2022 | 165 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7799 | 0.050 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2023 | 271 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.050 |
Why?
|
Genes, BRCA2 | 1 | 2004 | 618 | 0.050 |
Why?
|
TRPV Cation Channels | 1 | 2022 | 236 | 0.050 |
Why?
|
Stathmin | 1 | 2020 | 71 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 5021 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2529 | 0.050 |
Why?
|
Female | 14 | 2020 | 380194 | 0.040 |
Why?
|
Alleles | 4 | 2015 | 6933 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2021 | 319 | 0.040 |
Why?
|
United States | 6 | 2020 | 69872 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6773 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15076 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 426 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1058 | 0.040 |
Why?
|
Registries | 3 | 2024 | 8089 | 0.040 |
Why?
|
Medical History Taking | 1 | 2022 | 783 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2018 | 326 | 0.040 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2018 | 462 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2022 | 77449 | 0.040 |
Why?
|
Hawaii | 2 | 2006 | 105 | 0.040 |
Why?
|
Selenium-Binding Proteins | 1 | 2016 | 14 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2016 | 31 | 0.030 |
Why?
|
Androgens | 1 | 2024 | 1281 | 0.030 |
Why?
|
Seasons | 2 | 2012 | 1493 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12245 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1619 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5172 | 0.030 |
Why?
|
Phospholipids | 1 | 2018 | 784 | 0.030 |
Why?
|
Norway | 1 | 2016 | 448 | 0.030 |
Why?
|
Germ Cells | 1 | 2018 | 631 | 0.030 |
Why?
|
Finland | 1 | 2016 | 602 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 1999 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13102 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2118 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2015 | 279 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16365 | 0.030 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 802 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2011 | 11483 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4851 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2050 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 738 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 492 | 0.030 |
Why?
|
Retinoid X Receptor alpha | 1 | 2012 | 17 | 0.030 |
Why?
|
Epithelium | 1 | 2017 | 1679 | 0.030 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 61 | 0.030 |
Why?
|
Steroid Hydroxylases | 1 | 2012 | 96 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1782 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2420 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 9239 | 0.020 |
Why?
|
Biological Transport | 1 | 2016 | 2118 | 0.020 |
Why?
|
Vitamin D-Binding Protein | 1 | 2012 | 129 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2454 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1170 | 0.020 |
Why?
|
Life Style | 1 | 2022 | 3835 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2309 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3558 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7785 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 13881 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 644 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5255 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1179 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4669 | 0.020 |
Why?
|
Bone and Bones | 1 | 2017 | 2575 | 0.020 |
Why?
|
Mice | 3 | 2018 | 81183 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 769 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3703 | 0.020 |
Why?
|
Human Genome Project | 1 | 2006 | 193 | 0.020 |
Why?
|
Los Angeles | 1 | 2006 | 238 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2006 | 322 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2892 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4217 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1758 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 684 | 0.010 |
Why?
|
Introns | 1 | 2006 | 991 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
Vitamins | 1 | 2012 | 1622 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2015 | 63114 | 0.010 |
Why?
|
California | 1 | 2006 | 1402 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3588 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8987 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7913 | 0.010 |
Why?
|
Animals | 3 | 2018 | 168757 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2437 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3200 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16689 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5720 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6600 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 35421 | 0.010 |
Why?
|
Population Surveillance | 1 | 2006 | 2616 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10481 | 0.010 |
Why?
|
Genome, Human | 1 | 2006 | 4420 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12797 | 0.010 |
Why?
|
MicroRNAs | 1 | 2009 | 3752 | 0.010 |
Why?
|
Computer Simulation | 1 | 2006 | 6196 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15540 | 0.010 |
Why?
|
Mutation | 1 | 2010 | 29786 | 0.000 |
Why?
|